Webber Naturals NMN 150 mg, 100 Vcapsules
- Source of vitamin B3, a factor in the maintenance of good health
- Contains a metabolically active form of vitamin B3, a precursor of NAD+
- Provides 300 mg of NMN per two vegetarian capsules daily
- Offers greater support than the NAD+ precursor nicotinamide riboside (NR)
- Suitable for vegetarians and vegans
Each capsule contains: | |
NMN (nicotinamide mononucleotide) | 150 mg |
Recommended dosage (adults): 1 capsule 2 times daily or as directed by a physician. Consult a physician for use beyond 6 weeks.
Free of artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, corn, egg, fish, shellfish, animal products, salt, tree nuts, or GMOs.
Webber Naturals NMN contains nicotinamide mononucleotide, a metabolically active source of vitamin B3 as a factor in the maintenance of good health. NMN is used by the body to produce nicotinamide adenine dinucleotide (NAD+), an important metabolite involved in hundreds of metabolic processes.
NAD+ (and its reduced form NADH) is found in every cell in the body where it has crucial roles in the mitochondria, the organelles that produce energy within our cells. NAD+ levels decline with age, often reaching half their youthful levels by middle age. As NAD+ levels decline, maintaining adequate levels of vitamin B3 and NAD+ precursors through dietary sources becomes important.
Vitamin B3 is available in various forms, including niacin, nicotinamide, and nicotinamide riboside (NR). However, these forms require additional conversion steps to become active NAD+. Because NMN is a direct precursor to NAD+, it is converted to NAD+ efficiently to replenish levels that actively support mitochondrial activity.
Supplementing with NMN offers greater support compared to the NAD+ precursor NR. Taking just two vegetarian capsules provides a daily dose of 300 mg of NMN. This non-GMO formula is vegetarian- and vegan-friendly and is a fantastic supplement for adults who are stressed, fatigued, or want to alleviate age-related declines in NAD+.